Loading provider…
Loading provider…
Neurological Surgery Physician in Los Angeles, CA
NPI: 1063830735Primary Employer
USC Care Medical Group, Inc
keckmedicine.org
HQ Phone
Get M.D. Frances's Phone NumberMobile
Get M.D. Frances's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
2016 - 2027
CA State Medical License

American Board of Psychiatry and Neurology
Neurology

Neurocritical Care Society
Certification of Emergency Neurological Life Support
UCLA David Geffen School of Medicine/UCLA Medical Center
Fellowship • Neuro-Oncology
2018 - 2020
University of Southern California/Los Angeles General Medical Center (USC/LA General)
Chief Residency • Neurology
2017 - 2018
Residency • Neurology
2015 - 2018
University of California (Irvine)
Internship • Transitional Year
2014 - 2015
Drexel University College Of Medicine
drexel.edu
Medical School
Until 2014
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 27 | 87 |
| 2 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 24 | 66 |
| 3 | 99223Initial hospital inpatient care, typically 70 minutes per day | 16 | 17 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 12 | 21 |
Authors: Lisa Nachtigall, Arati Desai, Eliza Geer, Viviane Tabar, Byram Ozer, Marc Rosenblum, Jamie Tisnado, Jorg Dietrich, Andrew Lin, Sharon Wardlaw, Nazanin Majd, Tejus Bale
Journal: Acta Neuropathol
Publication Date: 2024-05-17
The abscopal effect: systematic review in patients with brain and spine metastases.
Authors: Eric Chang, Frank Attenello, Jacob Ruzevick, Gabriel Zada, Jason Ye, Frank Attenello
Journal: Neurooncol Adv
Publication Date: 2022-08-19
Lead Sponsor: TVAX Biomedical
Intervention / Treatment: BIOLOGICAL: TVI-Brain-1, PROCEDURE: Standard of Care, RADIATION: Radiotherapy, DRUG: Temozolomide
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, DRUG: Temozolomide, PROCEDURE: Biospecimen Collection, DRUG: Selinexor
Lead Sponsor: Neonc Technologies, Inc.
Intervention / Treatment: DRUG: NEO100